In 2019, the Swiss Federal Council modified the Therapeutic Products Act (TPA) to facilitate market access, improve drug safety, and increase transparency in Switzerland’s P&MA system.

Windrose Consulting Group are pleased to welcome a new starter, Pamela Fetzer in our Luzern, Switzerland office.